Medallion Renews Strategy for US Rare Earth Element Supply Chain
VANCOUVER, British Columbia, May 26, 2020 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCPK: MLLOF; Frankfurt: MRDN) – “Medallion” […]
Rubicon Organics Announces Upsize of Previously Announced Private Placement to $11.1 Million
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.VANCOUVER, British Columbia, May 26, 2020 (GLOBE […]
Allot Launches BusinessSecure, a New Solution for Telcos to Protect Their Business Customers from Cyberattacks
Hod Hasharon, Israel, May 26, 2020 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of […]
Viomi Technology Co., Ltd Reports First Quarter 2020 Unaudited Financial Results
GUANGZHOU, China, May 26, 2020 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading IoT @ […]
36Kr Holdings Inc. Reports First Quarter 2020 Unaudited Financial Results
BEIJING, May 26, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent […]
Cannabis Sativa Reports Doubling Revenues in 2019, Projects Continued Revenue Growth in 2020
MESQUITE, May 26, 2020 (GLOBE NEWSWIRE) — Cannabis Sativa Reports Doubling Revenues in 2019, Projects Continued Revenue Growth in 2020MESQUITE, […]
RETRANSMISSION: Sienna Resources Acquires the Kuusamo PGE-Ni-Cu-Co Project in Finland
VANCOUVER, British Columbia, May 26, 2020 (GLOBE NEWSWIRE) — Sienna Resources Inc. (SIE—TSX.v) (A1XCQ0–FSE) (SNNAF—OTCBB) (May 25, 2020) (the “Company”) […]
Global Care Capital Inc. Announces Non-Binding LOI to Acquire 70% Interest in High Standard Health Care Generating $4 Million in Orders to Date
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 26, 2020 […]
Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
– Collaboration to explore multiple solid tumor cancer indications –– Initial development focused on multi-cohort trials in the U.S., Europe, China […]
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
Regulated information – Inside informationTrial met primary endpoint (p ˂0.0001) Well-tolerated; safety profile comparable to placebo Biologics License Application on track to […]
